Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05005026 · ClinicalTrials.gov registry record · NA
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
A NA study of Spinal Cord Injuries and Neuropathic Pain, sponsored by Texas A&M University.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 3
- Study locations
NCT05005026: Recruiting NA study of Spinal Cord Injuries and Neuropathic Pain, sponsored by Texas A&M University.
NCT05005026 is a NA study of Spinal Cord Injuries and Neuropathic Pain that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 250 participants, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (317% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05005026, a NA study of Spinal Cord Injuries and Neuropathic Pain, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.
Primary Outcome
The Numeric Rating Scale (NRS) measures pain intensity via 0-10 numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain imaginable.
Conditions Studied
Interventions
- OTHER VR Game 1
- OTHER VR Game 2
Study Locations (3)
Alabama
- University of Alabama at Birmingham - Birmingham
Texas
- Texas A&M University - College Station
New South Wales
- University of New South Wales - Sydney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-11-23 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT05005026 shows while recruiting
NCT05005026 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (317% higher).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which VR Game 1 is the first listed.
NCT05005026 reports a single indexed study location in Alabama, Texas, New South Wales.
Frequently Asked Questions
What is clinical trial NCT05005026 about?
NCT05005026 is a clinical study titled "Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury". The purpose of this study is to determine if playing a virtual reality walking game can help improve neuropathic pain in adults with chronic spinal cord injury.
What is the current status of trial NCT05005026?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-11-23. Estimated completion is 2026-09.
What conditions does trial NCT05005026 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Neuropathic Pain.
What interventions are being tested in trial NCT05005026?
The interventions under investigation include: VR Game 1 (OTHER), VR Game 2 (OTHER).
Who is sponsoring clinical trial NCT05005026?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05005026 being conducted?
This trial has 3 study locations across Alabama, Texas, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05005026's enrollment target sits among peer trials
250 7th of 202 higher than 195 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy